Morphine-modulated mast cell migration and proliferation during early stages of zymosan-induced peritonitis in CBA mice

Folia Biologica

Volumn 59, Issue 3-4, 2011, Pages 99-106

  Wypasek, Ewa ^a,b   Natorska, Joanna ^a,b   Stankiewicz, Elzbieta ^c   Kolaczkowska, Elzbieta ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Mast cell; Migration; Morphine; Peritonitis; Proliferation

Indexed keywords

MORPHINE SULFATE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FLOW CYTOMETRY; MALE; MAST CELL; MOUSE; NONHUMAN; PERITONITIS;

MUS;

EID: 80051703035     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: 10.3409/fb59_3-4.99-106     Document Type: Article

References (40)

1. AJUEBOR M. N., DASA. M., VIRAGL., FLOWER R. J., SZABOC., PERRETTI M. 1999. Role of resident peritoneal macrophages and mast cells in chemokine production and neutrophil migration in acute inflammation: evidence for an inhibitory loop involving endogenous IL-10. J. Immunol. 162:1685-1691.
2. AVANZI G. C., PORCU P., BRIZZI M. F., GHIGO D., BOSIA A., PEGORARO L. 1991. Interleukin 3-dependent proliferation of the human Mo-7e cell line is supported by discrete activation of late G1 genes. Cancer Res. 51: 1741-1743.
3. BRZEZINSKA-BLASZCZYK E., MISIAK-TLOCZEK A. 2007. The regulation of mast cell migration. Part 2: mast cell chemoattractants. Postepy Hig. Med. Dosw. 61: 493-499.
4. BLACKLIDGE K. H., BIDWELL Ch. A. 1993. Protocol for DNA measurement in fishes by flow cytometry. (In: Handbook of flow cytometry methods. J. P. Robinson, P. Darzynkiewicz, I. Dean, H. Dressler, H. Tanke, L. Wheeless ed. Wiley-Liss, New York): 225-228.
5. BUNDOC V. G., KEANE-MYERS A. 2007. IL-10 confers protection from mast cell degranulation in a mouse model of allergic conjunctivitis. Exp. Eye Res. 85: 575-579.
6. CHADZINSKA M., KOLACZKOWSKA E., SELJELID R., PLYTYCZ B. 1999. Morphine modulation of peritoneal inflammation in Atlantic salmon and CB6 mice. J. Leukoc. Biol. 65: 590-596.
7. CRIVELLATO E., RIBATTI D. 2010. The mast cell: an evolutionary perspective. Biol. Rev. Camb. Philos. Soc. 85: 347-360.
8. DEMO S. D., MASUDA E., ROSSI A. B., THRONDSET B. T., GERARD A. L., CHAN E. H., ARMSTRONG R. J., FOX B. P., LORENS J. B., PAYAN D. G., SCHELLER R. H., FISHER J. M. 1999. Quantitative measurement of mast cell degranulation using a novel flow cytometric annexin-V binding assay. Cytometry 36: 340-348.
9. DI BELLO M. G., MASINI E., IOANNIDES C., FOMUSI NDISANG J., RASPANTI S., BANI SACCHI T., MANNAIONI P. F. 1998. Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals. Inflamm. Res. 47: 122-130.
10. DOHERTY N. S., POUBELLE P., BORGEAT P., BEAVER T. H., WESTRICH G. L., SCHRADER N. L. 1985. Intraperitoneal injection of zymosan in mice induces pain, inflammation and the synthesis of peptidoleukotrienes and prostaglandin E2. Prostaglandins 30: 769-789.
11. DOUGHERTY R. H., SIDHU S. S., RAMAN K., SOLON M., SOLBERG O. D., CAUGHEY G. H., WOODRUFF P. G., FAHY J. V. 2010. Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J. Allergy Clin. Immunol. 125: 1046-1053.
12. EMADI-KHIAV B., MOUSLI M., BRONNER C., LANDRY Y. 1995. Human and rat cutaneous mast cells: involvement of a G protein in the response to peptideric stimuli. Eur. J. Pharmacol. 272: 97-102.
13. GODFRAIND C., LOUAHED J., FAULKNER H., VINK A., WARNIER G., GRENCIS R., RENAULD J. Ch. 1998. Intraepithelial infiltration by mast cells with both connective tissue-type and mucosal-type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J. Immunol. 160: 3989-3996.
14. GRIMM M. C., BEN-BARUCHA., TAUBD. D., HOWARDO. M. Z., RESAU J. H., WANG J. M., RICHARDSON R., SNYDERMAN R., OPPENHEIM J. J. 1998b. Opiates transdeactivate chemokine receptors: d and ě opiate receptormediated heterologous desensitization. J. Exp. Med. 188: 317-325.
15. GRIMMM. C., BEN-BARUCHA., TAUBD. D., HOWARDO. M. Z., WANG J. M., OPPENHEIM J. J. 1998a. Opiate inhibition of chemokine induced chemotaxis. Ann. NY Acad. Sci. 840: 9-20.
16. HAGEMANN I. S., NARZINSKI K. D., BARANSKI T. J. 2007. E2F8 is a nonreceptor activator of heterotrimeric G proteins. J. Mol. Signal 30: 2-3.
17. HU Z. Q., ZHAO W. H., SHIMAMURA T. 2007. Regulation of mast cell development by inflammatory factors. Curr. Med. Chem. 14: 3044-3050.
18. JOZAKI K., KURIU A., WAKI N., ADACHI S., YAMATODANI A., TARUI S. KITAMURA Y. 1990. Proliferative potential of murine peritoneal mast cells after degranulation induced by compound 48/80, substance P, tetradecanoylophorbol acetate, or calcium ionophore A23187. J. Immunol. 145: 4252-4256.
19. KLINKER J. F., SEIFERT R. 1997. Morphine and muscle relaxants are receptor-independent G-protein activators and cromolyn is an inhibitor of stimulated G-protein activity. Inflamm. Res. 46: 46-50.
20. KOLACZKOWSKA E., ARNOLD B., PLYTYCZ B. 2008a. Mast cell involvement in zymosan-induced peritonitis in C57Bl/6 mice. Centr. Eur. J Immunol. 33: 91-97.
21. KOLACZKOWSKA E., BARTECZKO M., PLYTYCZ B., ARNOLD B. 2008b. Role of lymphocytes in the course of murine zymosan-induced peritonitis. Inflamm. Res. 57: 272-278.
22. KOLACZKOWSKA E., SELJELID R., PLYTYCZ B. 2001a. Critical role of mast cells in morphine-mediated impairment of zymosan-induced peritonitis in mice. Inflamm. Res. 50:415-421.
23. KOLACZKOWSKA E., SELJELID R., PLYTYCZ B. 2001b. Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J. Leukoc. Biol. 69: 33-42.
24. LEVI-SCHAFFER F., SLOVIK D., ARMETTI L., PICKHOLTZ D., TOUITOU E. 2000. Activation and inhibition of mast cells degranulation affect their morphometric parameters. Life Sci. 66: 283-229.
25. MISIAK-TLOCZEK A., BRZEZINSKA-BLASZCZYK E. 2009. IL-6, but not IL-4, stimulates chemokinesis and TNF stimulates chemotaxis of tissue mast cells: involvement of both mitogen-activated protein kinases and phosphatidylinositol 3-kinase signalling pathways. APMIS. 117: 558-567.
26. MOUSLI M., BRONNER C., LANDRY Y., BOCKAERT J., ROUOT B. 1990. Direct activation of GTP-binding proteins (G-proteins) by substance P and compound 48/80. FEBS Lett. 259: 260-262.
27. NATORSKA J., PLYTYCZ B. 2005. Strain-specific differences in modulatory effects of morphine on peritoneal inflammation in mice. Folia Biol. (Kraków) 53: 189-195.
28. OKAYAMA Y., KAWAKAMI T. 2006. Development, migration, and survival of mast cells. Immunol. Res. 34: 97-115.
29. PLYTYCZ B., NATORSKA J. 2002. Morphine attenuates pain and prevents inflammation in experimental peritonitis. Trends Immunol. 23: 345-346.
30. SHEEN C. H., SCHLEIMER R. P., KULKA M. 2007. Codeine induces human mast cell chemokine and cytokine production: involvement of G-protein activation. Allergy 62: 532-538.
31. SHIN K., NIGROVIC P. A., CRISH J., BOILARD E., MCNEIL H. P., LARABEE K. S., ADACHI R., GURISH M. F., GOBEZIE R., STEVENS R. L., LEE D. M. 2009. Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes. J. Immunol. 182: 647-656.
32. STANKIEWICZ E., WYPASEK E., PLYTYCZ B. 2001. Opposite effects of mast cell degranulation by compound 48/80 on peritoneal inflammation in Swiss and CBA mice. Pol. J. Pharmacol 53: 149-155.
33. STANKIEWICZ E., WYPASEK E., PLYTYCZ B. 2004. Mast cells are responsible for the lack of anti-inflammatory effects of morphine in CBA mice. Mediators Inflam. 13: 365-368.
34. STELEKATI E., ORINSKA Z., BULFONE-PAUS S. 2007. Mast cells in allergy: innate instructors of adaptive responses. Immunobiology 212: 505-519.
35. SZABO I., CHEN X. H., XIN L., ADLER M. W., HOWARD O. M., OPPENHEIM J. J., ROGERS T. J. 2002. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. USA 6: 10276-10281.
36. TANIZAKI Y., OHTANI J., KIMURA I. 1992. Actions and cross-reactivity of antiallergic agents and a calcium channel antagonist on rat peritoneal mast cells. Difference in the action mechanisms and cross-reactivity among the agents. Agents Actions 37: 8-15.
37. THURMOND R. L., DESAI P. J., DUNFORD P. J., FUNG-LEUNG W. P., HOFSTRA C. L., JIANG W., NGUYEN S., RILEY J. P., SUN S., WILLIAMS K. N., EDWARDS J. P., KARLSSON L. 2004. A potent and selective histamine H4 receptor antagonist with anti-inflammatory properties. J. Pharmacol. Exp. Ther. 309: 404-413.
38. VERBSKY J. W., MCALLISTER P. K., MALONE D. G. 1996. Mast cell activation in human synovium explants by calcium ionophore A23187, compound 48/80, and rabbit IgG anti-human IgE, but notmorphine sulfate. Inflamm. Res. 45: 35-41.
39. WELLER C. L., COLLINGTON S. J., BROWN J. K., MILLER H. R., AL-KASHI A., CLARK P., JOSE P. J., HARTNELL A., WILLIAMS T. J. 2005. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J. Exp. Med. 201: 1961-1971.
40. WELLER C. L., COLLINGTON S. J., HARTNELL A., CONROY D. M., KAISE T., BARKER J. E., WILSON M. S., TAYLOR G. W., JOSE P. J., WILLIAMS T. J. 2007. Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3. Proc. Natl. Acad. Sci. USA. 104: 11712-11717.